ICU Medical Inc (NASDAQ: ICUI ) reported Q2 sales of $561 million , up 75% Y/Y, due to Smiths Medical''s acquisition, and missing the consensus of $566.47 million. Adjusted EPS fell from $1.88 to $1.37, missing the consensus of $1.86. Guidance: ICU Medical forecasts FY22 adjusted EBITDA of $350-$370 million, down from a … Full story available on Benzinga.com
ICU Medical (NASDAQ: ICUI ) reported its Q2 earnings results on Monday, August 8, 2022 at 04:00 PM. Here''s what investors need to know about the announcement. Earnings ICU Medical missed estimated earnings by 26.34%, reporting an EPS of $1.37 versus an estimate of $1.86. Revenue was up $239.33 million from the same period last … Full story available on Benzinga.com
ICU Medical, Inc. (NASDAQ:NASDAQ:ICUI) Q2 2022 Earnings Conference Call August 8, 2022, 4:30 PM ET Company Participants John Mills - ICR Vivek Jain - CEO & Chairman Brian Bonnell - CFO…
ICU Medical press release (ICUI): Q2 Non-GAAP EPS of $1.37 misses by $0.29.Revenue of $561M (+74.4% Y/Y) misses by $3.1M.
Company Updated FY 2022 Guidance Company Updated FY 2022 Guidance
Related Stocks: BKNG , TDY , FARO , GOOGL , ICUI ,
The U.S. Food and Drug Administration ((FDA)) on Wednesday classified the recall of some syringe infusion pumps by ICU Medical (ICUI) company Smiths Medical as the most serious type